* TELA Bio Inc TELA.OQ reported a quarterly adjusted loss
of 57 cents per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 52 cents per share.
* Revenue rose 44.1% to $7.65 million from a year ago; analysts
expected $7.55 million.
* TELA Bio Inc's reported EPS for the quarter was a loss of 57
cents.
* The mean earnings estimate of analysts had fallen by about 1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* TELA Bio Inc shares had fallen by 5.5% this quarter and
lost 14.1% so far this year.
* The company reported a quarterly loss of $8.27 million.
* Wall Street's median 12-month price target for TELA Bio Inc is
$20.00
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated November 10 at 10:41 p.m.
All figures in US dollars unless otherwise stated